Subscribe Now Subscribe Today
Science Alert Home Journals at Science Alert For Authors For Subscribers Contact Us
 
FOLLOW US:     Facebook    Twitter
   
 
    Publisher: Academic Journals Inc., USA
   
  Current Research in Tuberculosis is dedicated to publish high quality research work from all over the world on clinical and epidemiological aspects of tuberculosis. Scope of the journal includes: respiratory diseases and therapeutic interventions, adult and pediatric medicine, epidemiology, immunology and cell biology, physiology, pharmacology, occupational disorders, and the role of allergens and pollutants.

Current Research in Tuberculosis now accepting new submissions. Submit your best paper via online submission system.
  Editor-in-Chief:  Apply for Editor-in-Chief
 
 
Hiraishi, Y., S. Nandakumar, S.O. Choi, J.W. Lee and Y.C. Kim et al., 2011. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine, 29: 2626-2636.
CrossRef  |  Direct Link  |  
Muthu, S.E., S. Nandakumar and U.A. Rao, 2005. The effect of methanolic extract of Tamarindus indica Linn. on the growth of clinical isolates of Burkholderia pseudomallei. Indian J. Med. Res., 122: 525-528.
PubMed  |  Direct Link  |  
Nandakumar, S. and U. Kumaraguru, 2010. Heterologous CD8 T cell immune response to HSV induced by toll like receptor ligands. Cell. Immunol., 261: 114-121.
CrossRef  |  PubMed  |  Direct Link  |  
Nandakumar, S., C.W.T. Miller and U. Kumaraguru, 2009. T regulatory cells: An overview and intervention techniques to modulate allergy outcome. Clin. Mol. Allergy., 7: 5-5.
CrossRef  |  Direct Link  |  
Nandakumar, S., S.N. Woolard, D. Yuan, B.T. Rouse and U. Kumaraguru, 2008. Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J. Virol., 82: 10820-10831.
CrossRef  |  Direct Link  |  
Ni, L., C.J. Ma, Y. Zhang, S. Nandakumar and C.L. Zhang et al., 2011. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma. Immunol. Cell Biol., 89: 535-539.
PubMed  |  Direct Link  |  
Parthiban, R., S. Shanmugam, V. Velu, S. Nandakumar and E. Dhevahi et al., 2009. Transmission of hepatitis C virus infection from asymptomatic mother to child in Southern India. Int. J. Infect. Dis., 13: e394-e400.
CrossRef  |  PubMed  |  Direct Link  |  
Rodrigues, L., S. Nandakumar, C. Bonorino, B.T. Rouse and U. Kumaraguru, 2009. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Mol. Immunol., 46: 1494-1504.
CrossRef  |  PubMed  |  Direct Link  |  
Sable, S.B., M. Cheruvu, S. Nandakumar, S. Sharma and K. Bandyopadhyay et al., 2011. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS One, 6: e22718-e22718.
CrossRef  |  PubMed  |  Direct Link  |  
Saravanan, S., V. Velu, N. Kumarasamy, E.M. Shankar and S. Nandakumar et al., 2008. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, Southern India. Trans. R. Soc. Trop. Med. Hyg., 102: 793-796.
CrossRef  |  PubMed  |  Direct Link  |  
Saravanan, S., V. Velu, N. Kumarasamy, E.M. Shankar and S. Nandakumar et al., 2008. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int. J. Infect. Dis., 12: 513-518.
CrossRef  |  PubMed  |  Direct Link  |  
Saravanan, S., V. Velu, N. Kumarasamy, S. Nandakumar and K.G. Murugavel et al., 2007. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in South India. World J. Gastroenterol., 13: 5015-5020.
PubMed  |  Direct Link  |  
Saravanan, S., V. Velu, S. Nandakumar, V. Madhavan and U. Shanmugasundaram et al., 2009. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J. Microbiol. Immunol. Infect., 42: 122-128.
PubMed  |  Direct Link  |  
Shah, D., S. Nandakumar, G.B. Jaishankar, S. Chilakala, K. Wang and U. Kumaraguru, 2011. Pre-term exposure patterns in neonatal intensive care unit alters immunological outcome in neonates. J. Allergy Ther., 2: 106-106.
CrossRef  |  Direct Link  |  
Shanmugam, S., V. Velu, S. Nandakumar, V. Madhavan and U. Shanmugasundaram et al., 2008. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India. J. Microbiol. Biotechnol., 18: 1722-1728.
PubMed  |  Direct Link  |  
Sow, F.B., S. Nandakumar, V. Velu, K.L. Kellar and L.S. Schlesinger et al., 2011. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis, 91: 314-321.
CrossRef  |  PubMed  |  Direct Link  |  
Velu, V., S. Nandakumar, S. Shanmugam and S.P. Thyagarajan, 2007. Persistence of anti-HBs titers after two different doses of Genevac B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J. Gastroenterol., 26: 48-48.
PubMed  |  Direct Link  |  
Velu, V., S. Nandakumar, S. Shanmugam, E.M. Shankar, S. Thangavel, P.S. Kulkarni and S.P. Thyagarajan, 2007. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatric Infect. Dis. J., 26: 1038-1041.
PubMed  |  Direct Link  |  
Velu, V., S. Nandakumar, S. Shanmugam, S.S. Jadhav, P.S. Kulkarni and S.P. Thyagarajan, 2007. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J. Gastroenterol., 13: 3084-3089.
PubMed  |  Direct Link  |  
Velu, V., S. Saravanan, S. Nandakumar, E. Dhevahi and E.M. Shankar et al., 2008. Transmission of a determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers. Jpn. J. Infect. Dis., 61: 73-76.
PubMed  |  Direct Link  |  
Velu, V., S. Saravanan, S. Nandakumar, E.M. Shankar and A. Vengatesan et al., 2008. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. World J. Gastroenterol., 14: 3534-3540.
PubMed  |  Direct Link  |  
Vijayakumar, V., M. Shraddha, N. Subhadra, S. Saravanan, T. Sundararajan and S.P. Thyagarajan, 2004. Immunogenicity and safety of 10 mg and 20 mg doses of Genevac-B, a recombinant hepatitis B vaccine, in healthy adolescents. Indian J. Gastroenterol., 23: 34-35.
PubMed  |  Direct Link  |  

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 

                 home       |       journals        |       for authors       |       for subscribers       |       asci
          © Science Alert. All Rights Reserved